BOLT Bolt Biotherapeutics: Accounting Value per Share

Graphic logo of Bolt Biotherapeutics, Inc. (BOLT)

Bolt Biotherapeutics price action is driven by strict FDA oversight and a partnership with Pfizer, which is supported by the book value per share. The value of 6.58 represents the current figure for this metric. Business protection is based on unique ISAC patents, while operational flexibility is achieved by outsourcing antibody production and clinical trials to external contractors.

Bolt Bio (BOLT): Share Book Value from 07/04/2022 to 10/27/2026

Bolt Biotherapeutics Inc. - analytical breakdowns and key metrics (BOLT)

- price and consensus price forecast:
Price Chart Bolt Bio|BOLT - Price Target Chart
- market capitalization data:
Market Valuation Bolt Biotherapeutics, Inc.|BOLT - Aggregate Business Value
- book capitalization data:
Net Assets per Single Share Bolt Biotherapeutics|BOLT - Net Asset Value|Market Capitalization to Book Value Ratio boltbio.com|BOLT - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Bolt Biotherapeutics|BOLT - Long-Term Debt to Capital|Short-Term Debt to Equity Bolt Bio|BOLT - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Bolt Biotherapeutics, Inc.
Fundamental company valuation:boltbio.com - BOLT
Manufactured products of Bolt Bio

Bolt Biotherapeutics' development of innovative antibodies requires significant capital expenditures prior to the commercialization stage, which directly impacts equity dynamics. The book value per share reflects the difference between all company assets and liabilities, allowing investors to assess the real intrinsic value of their holding, stripped of market noise, through the book value per share history.

Competitors of Bolt Biotherapeutics (BOLT)

ARGX - Net Assets per Single Share|BioNTech Pharma (BNTX) - Net Assets per Single Share|ABVX - Accounting Value per Share|ADMA (admabiologics.com) - Book Price of a Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|Net Asset Value per Share AnaptysBio Inc ANAB|ATXS - Book Value per Share|ENGN: Net Assets per Single Share|Net Assets per Single Share RAPT|JBIO (Aerovate Therapeutics) - Net Asset Value per Share|Net Assets per Single Share Aclaris Therapeutics, Inc.|Net Assets per Single Share Kyverna Therapeutics Inc. (KYTX)|Accounting Value per Share Tiziana Life Sciences PLC|Book Price of a Share Cabaletta Bio Inc CABA|Accounting Value per Share Ventyx Biosciences|Accounting Value of a Share theratech.com THTX|AVTX - Book Value per Share|ELDN - Net Assets per Single Share|Agenus Inc - Book Value per Share|CLYM (Climb Bio, Inc) - Net Assets per Share|Net Assets per Single Share ZURA (Zura Bio Limited)|Net Asset Value per Share atyrpharma.com (ATYR)|Accounting Value per Share Adagene|Book Price of a Share ikenaoncology.com (IMA)|Book Value per Share Shattuck Labs|Accounting Value of a Share Equillium Inc EQ|CNTB (Connect Pharma) - Book Value per Share|IMUX: Net Asset Value per Share|Net Assets per Single Share atarabio.com ATRA|InflaRx (IFRX) - Accounting Value of a Share|XFOR (X4 Pharma) - Book Value per Share|Book Value per Share ACET|CELU - Net Assets per Single Share|Share Book Value inmunebio.com (INMB)|BRNS: Book Value per Share|KZR - Net Asset Value per Share|SAB Biotherapeutics, Inc - Accounting Value per Share|Akari Therapeutics, Plc (AKTX) - Book Value per Share|ENLV - Accounting Value per Share|Q32 Bio (QTTB) - Book Price of a Share|GOVX: Book Value per Share|Net Assets per Share Edesa Biotech Inc|Book Value per Share IBIO (iBio Corp)|Accounting Value per Share CARM (carismatx.com)|Net Assets per Single Share XTLB|Net Assets per Share HCW Biologics, Inc. HCWB|APVO - Book Value per Share|AIM: Net Assets per Single Share|Net Assets per Single Share ADTX|GRI (GRI Bio Corporation) - Net Asset Value per Share|Net Assets per Single Share XORTX Therapeutics Inc.|Net Assets per Single Share reshapelifesciences.com (HIND)|Accounting Value per Share Revelation Biosciences, Inc.|Book Price of a Share INDP (Indaptus Therapeutics Inc)|Scinai (SCNI) - Net Assets per Single Share|Share Book Value CalciMedica Inc CALI|Book Value per Share Affimed Therapeutics (AFMD)|ALLK - Accounting Value of a Share|HOOK: Book Value per Share|IGMS (IGM Biosciences) - Book Value per Share|ITOS - Net Assets per Single Share|Accounting Value of a Share OCEA|Net Assets per Single Share TCBP (TC Biopharm)|Accounting Value per Share thirdharmonicbio.com (THRD)